Results

eNauka >  Rezultati >  The Impact of Upadacitinib Versus Methotrexate Or Adalimumab on Individual and Composite Disease Measures in Patients with Rheumatoid Arthritis
Naziv The Impact of Upadacitinib Versus Methotrexate Or Adalimumab on Individual and Composite Disease Measures in Patients with Rheumatoid Arthritis
Autori: Van, Vollenhoven Ronald; Ostor, Andrew; Mysler, Eduardo; Damjanov, Nemanja S; Song, In-Ho; Song, Yanna; Suboticki, Jessica; Strand, Vibeke
Godina: 2020
Publikacija: ANNALS OF THE RHEUMATIC DISEASES
ISSN: 0003-4967 Annals of the Rheumatic Diseases Pretraži identifikator
Tip rezultata: Konferencijski rad
Kolacija: vol. 79 br. Suppl 1 str. 647-652
DOI: 10.1136/annrheumdis-2020-eular.1426
WoS-ID: 000555905002103
URI: https://enauka.gov.rs/handle/123456789/811529
Izvor metapodataka: (Preuzeto iz Nasi u WoS)
M-kategorija: 
Mp kategorija će biti prikazana naknadno.

1
OpenCitations
Altmetric
Dimensions
Unpaywall

Google ScholarTM

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.